Mitochondria, Metabolism and Heart
joint with Heart Failure: Mechanisms and Therapies
Scientific Organizers: Elizabeth Murphy and Zoltan P. Arany
Date: February 26 - March 01, 2022
Location: Beaver Run Resort, Breckenridge, CO, USA
For important information on the coronavirus, please click here
Mitochondria are the established powerhouses of the cell, responsible for generating ATP via oxidative metabolism and electron transport. This conference will focus in on the role of mitochondria in heart health and metabolism. Mitochondrial transporters regulate mitochondrial calcium levels which in turn are important in regulating cell metabolism and death. Alterations in mitochondrial function and metabolism have been identified as important regulators of cardiovascular diseases like heart failure. Despite the importance of mitochondria in health and disease, the identity of many ion transporters is not yet known. In particular, the identity of the mitochondrial permeability pore that regulates cell death is still debated. In addition, the link from mitochondrial dynamics and metabolism to cell death is poorly understood. The conference program will emphasize experts using novel approaches such as high-resolution imaging techniques, metabolomics, proteomics and systems biology to elucidate mechanisms by which mitochondrial transporters and mitochondrial dynamics regulate metabolism, death and disease. Finally, this conference is paired with the Keystone Symposium on Heart Failure: Mechanisms and Therapies. This pairing will include two joint sessions will focus on mitochondrial function and metabolism, respectively.
Scholarship Deadline: November 16 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
We gratefully acknowledge the generous grant for this conference provided by:National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL154801-01
Funding for this conference was made possible (in part) by 1R13HL154801-01 from the National Heart, Lung and Blood Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.